Stimulus-responsive nanodelivery and release systems for cancer gene therapy: efficacy improvement strategies
H Zeng, Y Zhang, N Liu, Q Wei, F Yang… - International Journal of …, 2024 - Taylor & Francis
Introduction of exogenous genes into target cells to overcome various tumor diseases
caused by genetic defects or abnormalities and gene therapy, a new treatment method …
caused by genetic defects or abnormalities and gene therapy, a new treatment method …
[HTML][HTML] Gene Therapy for Retinitis Pigmentosa: Current Challenges and New Progress
Y Liu, X Zong, W Cao, W Zhang, N Zhang, N Yang - Biomolecules, 2024 - mdpi.com
Retinitis pigmentosa (RP) poses a significant threat to eye health worldwide, with
prevalence rates of 1 in 5000 worldwide. This genetically diverse retinopathy is …
prevalence rates of 1 in 5000 worldwide. This genetically diverse retinopathy is …
Efficient Rescue of Retinal Degeneration in Pde6a Mice by Engineered Base Editing and Prime Editing
Retinitis pigmentosa (RP) is a complex spectrum of inherited retinal diseases marked by the
gradual loss of photoreceptor cells, ultimately leading to blindness. Among these, mutations …
gradual loss of photoreceptor cells, ultimately leading to blindness. Among these, mutations …
Syndromic Retinitis Pigmentosa
JS Karuntu, H Almushattat, AS Plomp… - Progress in Retinal and …, 2024 - Elsevier
Retinitis pigmentosa (RP) is a progressive inherited retinal dystrophy, characterized by the
degeneration of photoreceptors, presenting as a rod-cone dystrophy. Approximately 20-30 …
degeneration of photoreceptors, presenting as a rod-cone dystrophy. Approximately 20-30 …
Feasibility of direct vitrectomy-sparing subretinal injection for gene delivery in large animals
Z Stranak, T Ardan, Y Nemesh, M Toms… - Current Eye …, 2024 - Taylor & Francis
Purpose To assess the safety and feasibility of direct vitrectomy-sparing subretinal injection
for gene delivery in a large animal model. Methods The experimental Liběchov minipigs …
for gene delivery in a large animal model. Methods The experimental Liběchov minipigs …
Accelerated discovery and miniaturization of novel single-stranded cytidine deaminases
J Deng, X Li, H Yu, L Yang, Z Wang, W Yi… - Nucleic Acids …, 2024 - academic.oup.com
Cytidine base editors (CBEs) hold significant potential in genetic disease treatment and in
breeding superior traits into animals. However, their large protein sizes limit their delivery by …
breeding superior traits into animals. However, their large protein sizes limit their delivery by …
[HTML][HTML] Strategies for organic nanoparticles delivering CRISPR/Cas9 for cancer therapy: Challenges and breakthroughs
T Zhang, Q Lv, M Zhao, Y Liu, Q Wang, Y Chen… - Materials & Design, 2024 - Elsevier
The recent years have witnessed the rapid advancement of clustered regularly interspaced
short palindromic repeats/associated protein 9 (CRISPR/Cas9)-mediated gene editing in …
short palindromic repeats/associated protein 9 (CRISPR/Cas9)-mediated gene editing in …
[HTML][HTML] Gene Therapy for Hearing Loss: Current Status and Future Prospects of Non-Viral Vector Delivery Systems
JC Leclère, R Marianowski, T Montier - Hearing Research, 2024 - Elsevier
Current therapeutic options for hearing loss rely on hearing aids, ossiculoplasty or cochlear
implants. These devices have limitations, particularly in noisy acoustic environments …
implants. These devices have limitations, particularly in noisy acoustic environments …
A Simple Nonviral Method to Generate Human Induced Pluripotent Stem Cells Using SMAR DNA Vectors
A Hartley, L Burger, CL Wincek, L Dons, T Li… - Genes, 2024 - mdpi.com
Induced pluripotent stem cells (iPSCs) are a powerful tool for biomedical research, but their
production presents challenges and safety concerns. Yamanaka and Takahashi …
production presents challenges and safety concerns. Yamanaka and Takahashi …
Key challenges in developing a gene therapy for Usher syndrome: machine-assisted scoping review
R Bhat, B Nallamothu, F Shethia, V Chhaya… - Journal of Community …, 2024 - Springer
Despite compelling empirical evidence demonstrating its efficacy, gene therapies for usher
syndrome (USH) are not yet available for the patient's usage. This scoping review assessed …
syndrome (USH) are not yet available for the patient's usage. This scoping review assessed …